Signals, Powered By EquityPandit
Lupin’s Pithampur unit 2 manufacturing facility located in Indore, has been cleared by Health Canada after a review.
In a BSE filing it stated, “Following the review, Health Canada has maintained the compliant rating for unit 2 at Pithampur (Indore) and has issued a revised Establishment License.”
Last year in November, 2017, it had received warning letter from US Food and Drug Administration for its manufacturing facilities in Goa and Pithampur, Indore.
